Seminar December 2021 – Professor Barenholz
On Friday, December 10, 2021, a seminar on "Liposomal Resolvin D1 for bone regeneration and treatment of osteoarthritis" was held at 11 a.m. (CET).
The speaker was Professor Dr. Yechezkel (Chezy) Barenholz from the Hebrew University of Jerusalem. Prof. Barenholz is one of the key inventors of Doxil®, the first FDA approved nano-drug (November 1995), marketed by Baxter for a cancer treatment. On October 2021, FDA approved a generic Doxil developed by Barenholz and his team.
If you need the slides of the presentation, please get in touch with us!